Fiera Capital Corp Charles River Laboratories International, Inc. Transaction History

Fiera Capital Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 12, 2019	SELL	$105.09 - $137.23 $184,958 - $241,524	-1,760 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$112.11 - $134.54 $197,313 - $236,790	1,760 New	1,760 $237,000
Q2 2018 Aug 02, 2018	SELL	$102.37 - $117.25 $8.59 Million - $9.84 Million	-83,901 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$98.19 - $115.2 $1.12 Million - $1.32 Million	-11,431 Reduced 11.99%	83,901 $8.96 Million
Q4 2017 Feb 09, 2018	SELL	$100.43 - $118.09 $1.91 Million - $2.24 Million	-18,991 Reduced 16.61%	95,332 $10.4 Million

Q3 2017 Nov 13, 2017	BUY	$96.72 - $109.26 $11.1 Million - $12.5 Million	114,323	114,323 $12.3 Million

644

51.6M

194K

174K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.54B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Fiera Capital Corp, based on Form 13F filings with the SEC.

Stay updated on Fiera Capital Corp with notifications on news.